{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:30:54Z","timestamp":1790620254588,"version":"4.1.0"},"reference-count":13,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1005068","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:44:07Z","timestamp":1777311847000},"page":"e1005068","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing dengue vaccination strategies"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0362-5375","authenticated-orcid":true,"given":"Annelies","family":"Wilder-Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"10169","key":"pmed.1005068.ref001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(18)32560-1","article-title":"Dengue","volume":"393","author":"A Wilder-Smith","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"pmed.1005068.ref002","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taae089","article-title":"Epidemiology of travel-associated dengue from 2007 to 2022: a GeoSentinel analysis","volume":"31","author":"A Duvignaud","year":"2024","journal-title":"J Travel Med"},{"issue":"11","key":"pmed.1005068.ref003","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/infdis\/jiz618","article-title":"Antibody-dependent enhancement of severe disease is mediated by serum viral load in pediatric dengue virus infections","volume":"221","author":"JJ Waggoner","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"pmed.1005068.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30494-8","article-title":"Deliberations of the strategic advisory group of experts on immunization on the use of CYD-TDV dengue vaccine","volume":"19","author":"A Wilder-Smith","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pmed.1005068.ref005","unstructured":"WHO. WHO Position Paper on TAK-003 dengue vaccine 2024. Available from: https:\/\/www.who.int\/publications\/i\/item\/who-wer-9918-203-224"},{"issue":"1","key":"pmed.1005068.ref006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/ciab864","article-title":"Three-year efficacy and safety of Takeda\u2019s dengue vaccine candidate (TAK-003)","volume":"75","author":"L Rivera","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pmed.1005068.ref007","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiae222","article-title":"Efficacy and safety of a tetravalent dengue vaccine (TAK-003) in children with prior Japanese encephalitis or yellow fever vaccination","volume":"230","author":"C Sirivichayakul","year":"2024","journal-title":"J Infect Dis"},{"issue":"2","key":"pmed.1005068.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00522-3","article-title":"Long-term efficacy and safety of a tetravalent dengue vaccine [TAK-003]: 4.5-year results from a phase 3, randomised, double-blind, placebo-controlled trial","volume":"12","author":"V Tricou","year":"2024","journal-title":"Lancet Glob Health"},{"issue":"6","key":"pmed.1005068.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004631","article-title":"Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: a modeling case study in Thailand","volume":"22","author":"J Shen","year":"2025","journal-title":"PLoS Med"},{"issue":"3","key":"pmed.1005068.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0014062","article-title":"Adult dengue vaccination in a low transmission setting: a modelling study in Singapore","volume":"20","author":"A Senapati","year":"2026","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pmed.1005068.ref011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(25)00382-2","article-title":"Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in S\u00e3o Paulo, Brazil: a test-negative, case-control study","volume":"26","author":"OT Ranzani","year":"2026","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pmed.1005068.ref012","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf004","article-title":"First clinical experiences with the tetravalent live vaccine against dengue (Qdenga) in travellers: a multicentric TravVacNet study in Germany","volume":"32","author":"C K\u00f6pke","year":"2025","journal-title":"J Travel Med"},{"key":"pmed.1005068.ref013","article-title":"Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine","author":"EG Kall\u00e1s","year":"2026","journal-title":"Nat Med"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:44:11Z","timestamp":1777311851000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1005068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1005068","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}